China Largest Factory Manufacturer sales USP, BP, EP, CP CROSCARMELLOSE SODIUM CAS 74811-65-7 CAS NO.74811-65-7

                                PRODUCT DETAILS       

Cas No. 74811-65-7  H.S. Code 39129000

Main Purpose: Tablet and capsule disintegrant.

Package: 25kg/fiber drum

Packing Size: D37cm*H53cm  

G.W. 27.5kg

CROSCARMELLOSE SODIUM Basic information Product Name: CROSCARMELLOSE SODIUM Synonyms: Sodiumcroscarmellose;CROSCARMELLOSE SODIUM;MODIFIED CELLULOSE GUM;PRIMELLOSE(R);Crosscarmelosesodium;Croscarmellose natrium;Cross-linked carboxymethylcellulose sodium;Unii-m28ol1hh48 CAS: 74811-65-7 MF: Null MW: 0 EINECS: 1312995-182-4 Product Categories:   Mol File: Mol File   CROSCARMELLOSE SODIUM Chemical Properties Melting point  >205oC (dec.) density  Bulk density (g/cc) 0.48 storage temp.  Hygroscopic, -20°C Freezer, Under inert atmosphere solubility  Practically insoluble in acetone, in anhydrous ethanol and in toluene. form  Solid color  White to Off-White EPA Substance Registry System Croscarmellose sodium (74811-65-7)   Safety Information MSDS Information   CROSCARMELLOSE SODIUM Usage And Synthesis Chemical Properties pH 5.0-7.0 tablet disintegrant. Chemical Properties Croscarmellose sodium occurs as an odorless, white or grayishwhite powder. Uses Packaged under nitrogen Uses antimicrobial Uses Used as Disintegrant in Capsules, Tablet and Granule Formulations. Uses Pharmaceutic aid (tablet disintegrant). Uses Croscarmellose Sodiumis a super disintegrant used in pharmaceuticals in the synthesis of tablets for oral administration. Production Methods Alkali cellulose is prepared by steeping cellulose, obtained from wood pulp or cotton fibers, in sodium hydroxide solution. The alkali cellulose is then reacted with sodium monochloroacetate to obtain carboxymethylcellulose sodium. After the substitution reaction is completed and all of the sodium hydroxide has been used, the excess sodium monochloroacetate slowly hydrolyzes to glycolic acid. The glycolic acid changes a few of the sodium carboxymethyl groups to the free acid and catalyzes the formation ofcrosslinkstoproducecroscarmellosesodium.Thecroscarmellose sodium is then extracted with aqueous alcohol and any remaining sodium chloride or sodium glycolate is removed. After purification, croscarmellose sodium of purity greater than 99.5% is obtained. The croscarmellose sodium may be milled to break the polymer fibers into shorter lengths and hence improve its flow properties. Brand name Ac-Di-Sol (FMC); CLD 2 (Buckeye). Pharmaceutical Applications Croscarmellose sodium is used in oral pharmaceutical formulations as a disintegrant for capsules,tablets, and granules. In tablet formulations, croscarmellose sodium may be used in bothdirect-compressionandwet-granulationprocesses.Whenused in wet granulations, the croscarmellose sodium should be added in both the wet and dry stages of the process (intra- and extragranularly) so that the wicking and swelling ability of the disintegrant is best utilized. Croscarmellose sodium at concentrations up to 5% w/w may be used as a tablet disintegrant, although normally 2% w/w is used in tablets prepared by direct compression and 3% w/w in tablets prepared by a wet-granulation process. Safety Croscarmellose sodium is mainly used as a disintegrant in oral pharmaceutical formulations and is generally regarded as an essentially nontoxic and nonirritant material. However, oral consumption of large amounts of croscarmellose sodium may have a laxative effect, although the quantities used in solid dosage formulations are unlikely to cause such problems. In the UK, croscarmellose sodium is accepted for use in dietary supplements. The WHO has not specified an acceptable daily intake for the related substance carboxymethylcellulose sodium, used as a food additive, since the levels necessary to achieve a desired effect were not considered sufficient to be a hazard to health. storage Croscarmellose sodium is a stable though hygroscopic material. A model tablet formulation prepared by direct compression, withcroscarmellosesodiumasadisintegrant,showednosignificant differenceindrugdissolutionafterstorageat30°Cfor14months. Croscarmellose sodium should be stored in a well-closed container in a cool, dry place. Incompatibilities The efficacy of disintegrants, such as croscarmellose sodium, may be slightly reduced in tablet formulations prepared by either the wet-granulation or direct-compression process that contain hygroscopic excipients such as sorbitol. Croscarmellose sodium is not compatible with strong acids or with soluble salts of iron and some other metals such as aluminum, mercury, and zinc. Regulatory Status Included in the FDA Inactive Ingredients Database (oral capsules, granules, sublingual tablets, and tablets). Included in nonparenteral medicines licensed in the UK. Included in the Canadian List of Acceptable Non-medicinal Ingredients.   CROSCARMELLOSE SODIUM Preparation Products And Raw materials

                                                                About Our Group

Leader Biochemical Group is a large leader incorporated industry manufacturers and suppliers of advanced refined raw materials From the year of 1996 when our factory was put into production to year of 2020, our group has successively invested in more than 52 factories with shares and subordinates.We focus on manufacture Pharm & chemicals, functional active ingredients, nutritional Ingredients, health care products, cosmetics, pharmaceutical and refined feed, oil, natural plant ingredients industries to provide top quality of GMP standards products.All the invested factories' product lines cover API and intermediates, vitamins, amino acids, plant extracts, daily chemical products, cosmetics raw materials, nutrition and health care products, food additives, feed additives, essential oil products, fine chemical products and agricultural chemical raw materials And flavors and fragrances. Especially in the field of vitamins, amino acids, pharmaceutical raw materials and cosmetic raw materials, we have more than 20 years of production and sales experience. All products meet the requirements of high international export standards and have been recognized by customers all over the world. Our manufacture basement & R&D center located in National Aerospace Economic & Technical Development Zone Xi`an Shaanxi China. Now not only relying on self-cultivation and development as well as maintains good cooperative relations with many famous research institutes and universities in China. Now, we have closely cooperation with Shanghai Institute of Organic Chemistry of Chinese Academy of Science, Beijing Institute of Material Medical of Chinese Academy of Medical Science, China Pharmaceutical University, Zhejiang University. Closely cooperation with them not only integrating Science and technology resources, but also increasing the R&D speed and improving our R&D power. Offering Powerful Tech supporting Platform for group development. Keep serve the manufacture and the market as the R&D central task, focus on the technical research.  Now there are 3 technology R & D platforms including biological extract, microorganism fermentation and chemical synthesis, and can independently research and develop kinds of difficult APIs and pharmaceutical intermediates. With the strong support of China State Institute of Pharmaceutical Industry (hereinafter short for CSIPI), earlier known as Shanghai Institute of Pharmaceutical Industry (SIPI), we have unique advantages in the R & D and industrialization of high-grade, precision and advanced products.  Now our Group technical force is abundant, existing staff more that 1000 people, senior professional and technical staff accounted for more than 50% of the total number of employees, including 15 PhD research and development personnel, 5 master′ S degree in technical and management personnel 9 people. We have advanced equipment like fermentation equipment and technology also extraction, isolation, purification, synthesis with rich production experience and strict quality control system, According to the GMP required, quickly transforming the R&D results to industrial production in time, it is our advantages and our products are exported to North and South America, Europe, Middle East, Africa, and other five continents and scale the forefront in the nation, won good international reputation.  We believe only good quality can bring good cooperation, quality is our key spirit during our production, we are warmly welcome clients and partner from all over the world contact us for everlasting cooperation, Leader will be your strong, sincere and reliable partner in China.

                                                                      Our Group profiles

Our Factories production lines

                                                   Our Factories R&D ability

                        Our Factories warehouse 

                                                       Product information

Cas No. 74811-65-7  H.S. Code 39129000

Main Purpose: Tablet and capsule disintegrant.

Package: 25kg/fiber drum

Packing Size: D37cm*H53cm  

G.W. 27.5kg

CROSCARMELLOSE SODIUM Basic information Product Name: CROSCARMELLOSE SODIUM Synonyms: Sodiumcroscarmellose;CROSCARMELLOSE SODIUM;MODIFIED CELLULOSE GUM;PRIMELLOSE(R);Crosscarmelosesodium;Croscarmellose natrium;Cross-linked carboxymethylcellulose sodium;Unii-m28ol1hh48 CAS: 74811-65-7 MF: Null MW: 0 EINECS: 1312995-182-4 Product Categories:   Mol File: Mol File   CROSCARMELLOSE SODIUM Chemical Properties Melting point  >205oC (dec.) density  Bulk density (g/cc) 0.48 storage temp.  Hygroscopic, -20°C Freezer, Under inert atmosphere solubility  Practically insoluble in acetone, in anhydrous ethanol and in toluene. form  Solid color  White to Off-White EPA Substance Registry System Croscarmellose sodium (74811-65-7)   Safety Information MSDS Information   CROSCARMELLOSE SODIUM Usage And Synthesis Chemical Properties pH 5.0-7.0 tablet disintegrant. Chemical Properties Croscarmellose sodium occurs as an odorless, white or grayishwhite powder. Uses Packaged under nitrogen Uses antimicrobial Uses Used as Disintegrant in Capsules, Tablet and Granule Formulations. Uses Pharmaceutic aid (tablet disintegrant). Uses Croscarmellose Sodiumis a super disintegrant used in pharmaceuticals in the synthesis of tablets for oral administration. Production Methods Alkali cellulose is prepared by steeping cellulose, obtained from wood pulp or cotton fibers, in sodium hydroxide solution. The alkali cellulose is then reacted with sodium monochloroacetate to obtain carboxymethylcellulose sodium. After the substitution reaction is completed and all of the sodium hydroxide has been used, the excess sodium monochloroacetate slowly hydrolyzes to glycolic acid. The glycolic acid changes a few of the sodium carboxymethyl groups to the free acid and catalyzes the formation ofcrosslinkstoproducecroscarmellosesodium.Thecroscarmellose sodium is then extracted with aqueous alcohol and any remaining sodium chloride or sodium glycolate is removed. After purification, croscarmellose sodium of purity greater than 99.5% is obtained. The croscarmellose sodium may be milled to break the polymer fibers into shorter lengths and hence improve its flow properties. Brand name Ac-Di-Sol (FMC); CLD 2 (Buckeye). Pharmaceutical Applications Croscarmellose sodium is used in oral pharmaceutical formulations as a disintegrant for capsules,tablets, and granules. In tablet formulations, croscarmellose sodium may be used in bothdirect-compressionandwet-granulationprocesses.Whenused in wet granulations, the croscarmellose sodium should be added in both the wet and dry stages of the process (intra- and extragranularly) so that the wicking and swelling ability of the disintegrant is best utilized. Croscarmellose sodium at concentrations up to 5% w/w may be used as a tablet disintegrant, although normally 2% w/w is used in tablets prepared by direct compression and 3% w/w in tablets prepared by a wet-granulation process. Safety Croscarmellose sodium is mainly used as a disintegrant in oral pharmaceutical formulations and is generally regarded as an essentially nontoxic and nonirritant material. However, oral consumption of large amounts of croscarmellose sodium may have a laxative effect, although the quantities used in solid dosage formulations are unlikely to cause such problems. In the UK, croscarmellose sodium is accepted for use in dietary supplements. The WHO has not specified an acceptable daily intake for the related substance carboxymethylcellulose sodium, used as a food additive, since the levels necessary to achieve a desired effect were not considered sufficient to be a hazard to health. storage Croscarmellose sodium is a stable though hygroscopic material. A model tablet formulation prepared by direct compression, withcroscarmellosesodiumasadisintegrant,showednosignificant differenceindrugdissolutionafterstorageat30°Cfor14months. Croscarmellose sodium should be stored in a well-closed container in a cool, dry place. Incompatibilities The efficacy of disintegrants, such as croscarmellose sodium, may be slightly reduced in tablet formulations prepared by either the wet-granulation or direct-compression process that contain hygroscopic excipients such as sorbitol. Croscarmellose sodium is not compatible with strong acids or with soluble salts of iron and some other metals such as aluminum, mercury, and zinc. Regulatory Status Included in the FDA Inactive Ingredients Database (oral capsules, granules, sublingual tablets, and tablets). Included in nonparenteral medicines licensed in the UK. Included in the Canadian List of Acceptable Non-medicinal Ingredients.   CROSCARMELLOSE SODIUM Preparation Products And Raw materials